EMEA-001212-PIP01-11
Key facts
| Invented name |
Kineret
|
| Active substance |
anakinra
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0066/2012
|
| PIP number |
EMEA-001212-PIP01-11
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Swedish Orphan Biovitrum AB
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-001212-PIP01-11
|
| Compliance opinion date |
12/12/2014
|
| Compliance outcome |
positive
|